BIORA THERAPEUTICS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenues
Cost of sales
Operating expenses:
Research and development
Selling and marketing
General and administrative
Selling, general and administrative
Total operating expenses
Loss from operations
Interest expense, net
Other (expense) income, net
Loss before income taxes
Income tax benefit
Loss from continuing operations
Gain from discontinued operations
Net loss
Dividend paid to preferred stockholders
Net loss attributable to common stockholders
Net loss per share from continuing operations, basic and diluted
Net loss per share from discontinued operations, basic and diluted
Net loss per share, basic and diluted
Net loss per share attributable to common stockholders, basic and diluted
Weighted average shares outstanding, basic and diluted
Net loss per share from continuing operations, basic
Net loss per share from continuing operations, diluted
Net gain per share from discontinued operations, basic
Net gain per share from discontinued operations, diluted
Net loss per share, basic
Net loss per share, diluted
Weighted average shares outstanding, basic
Weighted average shares outstanding, diluted

Comments